Overexpression of hypoxia-inducible factor 1 alpha is a marker for an unfavorable prognosis in early stage invasive cervical cancer
Birner P, Schendl M, Obermair A, et al. Overexpression of hypoxia-inducible factor 1 alpha is a marker for an unfavorable prognosis in early stage invasive cervical cancer. Cancer Res, 2000;60(17):4693-4696.
Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells
Price DJ, Miralem T, Jiang S, et al. Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells. Cell Growth Differ, 2001; 12(3):129-135.
Expression of hypoxia-inducible factor-1α and cell cycle proteins in invasive breast cancer are estrogen receptor related
Bos R, van Diest PJ, van der Groep P, et al. Expression of hypoxia-inducible factor-1α and cell cycle proteins in invasive breast cancer are estrogen receptor related. Breast Cancer Res, 2004;6(4):450-459.
Up-regulation of hypoxia-inducible factor 1 alpha is an early event in prostate carcinogenesis
Zhong H, Semenza GL, Simons JW. Up-regulation of hypoxia-inducible factor 1 alpha is an early event in prostate carcinogenesis. Cancer Det and Prey, 2004;28(2):88-93.
Prognostic factors affecting disease-free survival rate following surgical resection of primary breast cancer
Horita K, Yamaguchi A, Hirose K, et al. Prognostic factors affecting disease-free survival rate following surgical resection of primary breast cancer. Eur J Histochem, 2001;45(1):73-84.
Constitutive expression of hypoxia-inducible factor-1α renders pancreatic cancer cell resistant to apoptosis induced by hypoxia and nutrient deprivation
Akakura N, Kobayashi M, Horiuchi I, et al. Constitutive expression of hypoxia-inducible factor-1α renders pancreatic cancer cell resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Res, 2001;61(17):6548-6554.
Evaluating hypoxia-inducible factor 1 alpha as a cancer therapeutic target via inducible RNA interference in vivo
Li L, Lin X, Staver M, et al. Evaluating hypoxia-inducible factor 1 alpha as a cancer therapeutic target via inducible RNA interference in vivo. Cancer Res, 2005;65(16):7249-7258.